Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: An institutional experience

Bone Marrow Transplantation

Volumn 37, Issue 1, 2006, Pages 73-80

  Berman, J N ^a,b   Wang, M ^a   Berry, W ^a   Neuberg, D S ^a   Guinan, Eva C ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Herpes virus infection; Pediatric transplantation; Transaminitis

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FAMCICLOVIR; GANCICLOVIR; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DONOR; EARLY DIAGNOSIS; GRAFT VERSUS HOST REACTION; HERPES ZOSTER; HOSPITALIZATION; HUMAN; HUMAN CELL; INCIDENCE; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SERODIAGNOSIS; SKIN INFECTION; STATISTICAL ANALYSIS; TREATMENT PLANNING; VARICELLA ZOSTER VIRUS; VISCERA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; MALE; RISK FACTORS; TRANSAMINASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 31344480130     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705191     Document Type: Article

References (30)

1. Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: Frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000; 6: 44-49.
2. Rogers SY, Irving W, Harris A, Russell NH. Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transplant 1995; 15: 805-807.
3. Schiller GJ, Nimer SD, Gajewski JL, Golde DW. Abdominal presentation of varicella-zoster infection in recipients of allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 7: 489-491.
4. Kawasaki H, Takayama J, Ohira M. Herpes zoster infection after bone marrow transplantation in children. J Pediatr 1996; 128: 353-356.
5. Nakayama H, Okamura J, Ohga S, Miyazaki C, Matsuzaki A, Ikuno Y et al. Herpes zoster in children with bone marrow transplantation: Report from a single institution. Acta Paediatr JPN 1995; 37: 302-307.
6. Sauerbrei A, Prager J, Hengst U, Zintl F, Wutzler P. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 381-383.
7. Wacker P, Hartmann O, Benhamou E, Salloum E, Lemerle J. Varicella-zoster virus infections after autologous bone marrow transplantation in children. Bone Marrow Transplant 1989; 4: 191-194.
8. Takaue Y, Okamoto Y, Kawano Y, Suzue T, Abe T, Saito SI et al. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplant 1994; 14: 219-223.
9. Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 25: 167-172.
10. Schuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos GW, Saral R et al. Herpes zoster infection after autologous bone marrow transplantation. Blood 1989; 74: 1424-1427.
11. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985; 152: 1172-1181.
12. Han CS, Miller W, Haake R, Weisdorf D. Varicella zoster infection after bone marrow transplantation: Incidence, risk factors and complications. Bone Marrow Transplant 1994; 13: 277-283.
13. Steer CB, Szer J, Sasadeusz J, Matthews JP, Beresford JA, Grigg A et al. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplant 2000; 25: 657-664.
14. Hurd DD, LeBien TW, Lasky LC, Haake RJ, Ramsay NK, Kim TH et al. Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med 1988; 85: 829-834.
15. Sallan SE, Niemeyer CM, Billett AL, Lipton JM, Tarbell NJ, Gelber RD et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia. J Clin Oncol 1989; 7: 1594-1601.
16. Grupp SA, Stern JW, Bunin N, Nancarrow C, Ross AA, Mogul M et al. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 2000; 18: 2567-2575.
17. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
18. Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ et al. IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. Br J Haematol 1997; 97: 855-864.
19. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993; 12: 737-751.
20. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
21. Grow WB, Moreb JS, Roque D, Manion K, Leather H, Reddy V et al. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant 2002; 29: 15-19.
22. Kook H, Goldman F, Padley D, Giller R, Rumelhart S, Holida M et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996; 88: 1089-1097.
23. Small TN, Papadopoulos EB, Boulad F, Black P, Castro-Malaspina H, Childs BH et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467-480.
24. Godthelp BC, van Tol MJ, Vossen JM, van Den Elsen PJ. T-cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires. Blood 1999; 94: 4358-4369.
25. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 2002; 347: 26-34.
26. Bilgrami S, Chakraborty NG, Rodriguez-Pinero F, Khan AM, Feingold JM, Bona RD et al. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue. Bone Marrow Transplant 1999; 23: 469-474.
27. Witherspoon RP, Kopecky K, Storb RF, Flournoy N, Sullivan KM, Sosa R et al. Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancy. Transplantation 1982; 33: 143-149.
28. Callum JL, Brandwein JM, Sutcliffe SB, Scott JG, Keating A. Influence of total body irradiation on infections after autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 245-251.
29. Ljungman P, Lonnqvist B, Gahrton G, Ringden O, Sundqvist VA, Wahren B et al. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis 1986; 153: 840-847.
30. Pepe M, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993; 12: 737-751.